Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report)’s share price was up 12.8% during mid-day trading on Friday . The stock traded as high as $2.04 and last traded at $2.0299. Approximately 920 shares changed hands during trading, a decline of 90% from the average daily volume of 9,115 shares. The stock had previously closed at $1.80.
Silence Therapeutics Price Performance
The business has a 50 day moving average price of $1.70 and a 200 day moving average price of $1.62.
About Silence Therapeutics
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
See Also
- Five stocks we like better than Silence Therapeutics
- How to Short Nasdaq: An Easy-to-Follow Guide
- Synopsys Sees Bullish Shift as Ansys Integration Drives Growth
- What Are Dividend Challengers?
- The Best Holiday Present You Can Give Yourself? Costco Stock
- Are Penny Stocks a Good Fit for Your Portfolio?
- Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
